MYMOP - Measure Yourself Medical Outcome Profile: Difference between revisions
Oyemi Sillo (talk | contribs) mNo edit summary |
Kim Jackson (talk | contribs) (Removed copyright protected images) |
||
| Line 5: | Line 5: | ||
</div> | </div> | ||
== Introduction == | == Introduction == | ||
MYMOP® is a problem specific and individualised measure, which is brief and simple to use. was originally created in 1996.<ref>Mirza S, Salisbury C, Hopper C, Foster N, Montgomery A. [https://link.springer.com/article/10.1186/1745-6215-14-S1-O50 Comparing sensitivity to change of two patient-reported outcome measures in a randomised trial of patients referred for physiotherapy services]. Trials. 2013 Nov 1;14(S1):O50.</ref><ref name=":3">Polus BI, Kimpton AJ, Walsh MJ. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071331/ Use of the measure your medical outcome profile (MYMOP2) and W-BQ12 (Well-Being) outcomes measures to evaluate chiropractic treatment: an observational study]. Chiropractic & manual therapies. 2011 Dec;19(1):7.</ref> MYMOP®' measures capture what patients consider are the two most important symptoms associated with a specific problem and an activity of daily living that is affected by these symptoms. MYMOP® also captures general wellbeing and is therefore applicable to all people who present with symptoms, whether physical, emotional or social. MYMOP® asks a person about medication use related to their problem and whether they want to cut this down.<ref>Paterson C, Langan CE, McKaig GA, Anderson PM, Maclaine GD, Rose LB, Walker SJ, Campbell MJ. [https://link.springer.com/article/10.1023/A:1008930521566 Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D).] Quality of Life Research. 2000 May 1;9(5):521-7.</ref>. | |||
{{#ev:youtube|IS4pblMO5RI|300}}<ref>getwelluk. What is MYMOP? Available from: http://www.youtube.com/watch?v=IS4pblMO5RI [last accessed 15/1/2023]</ref> | |||
== Description == | == Description == | ||
The MYMOP tool is completed in the initial consultation. One or two symptoms are listed which are effected by the patient's condition such as "right leg weakness", this is then rated by the patient on a scale 0-6 taking into consideration their symptoms over the last week. This rating scale should be done by the patient and not influenced by the practitioner.<ref name=":2">Hermann K, Kraus K, Herrmann K, Joos S. [https://hqlo.biomedcentral.com/articles/10.1186/s12955-014-0112-5 A brief patient-reported outcome instrument for primary care: German translation and validation of the Measure Yourself Medical Outcome Profile (MYMOP)]. Health and quality of life outcomes. 2014 Dec;12(1):112.</ref> | The MYMOP tool is completed in the initial consultation. One or two symptoms are listed which are effected by the patient's condition such as "right leg weakness", this is then rated by the patient on a scale 0-6 taking into consideration their symptoms over the last week. This rating scale should be done by the patient and not influenced by the practitioner.<ref name=":2">Hermann K, Kraus K, Herrmann K, Joos S. [https://hqlo.biomedcentral.com/articles/10.1186/s12955-014-0112-5 A brief patient-reported outcome instrument for primary care: German translation and validation of the Measure Yourself Medical Outcome Profile (MYMOP)]. Health and quality of life outcomes. 2014 Dec;12(1):112.</ref> | ||
| Line 22: | Line 14: | ||
The patient would then choose an activity that has been effected by the symptom, and again rate the activity on a scale of 0-6 over the last week. The patient can also rate their well-being on the same scale however it is not essential for the data analysis. | The patient would then choose an activity that has been effected by the symptom, and again rate the activity on a scale of 0-6 over the last week. The patient can also rate their well-being on the same scale however it is not essential for the data analysis. | ||
A minimum clinically important change in score after intervention should be between '''0.5-1.0''': any change greater than '''1.0''' can be considered clinically significant.<ref name=":3" />{{#ev:youtube|w8d0w38n-eI|300}}<ref>getwelluk. How Do I Use MYMOP? Available from: http://www.youtube.com/watch?v=w8d0w38n-eI [last accessed 15/1/2023]</ref> | |||
A minimum clinically important change in score after intervention should be between '''0.5-1.0''': any change greater than '''1.0''' can be considered clinically significant.<ref name=":3" /> | |||
{{#ev:youtube|w8d0w38n-eI|300}}<ref>getwelluk. How Do I Use MYMOP? Available from: http://www.youtube.com/watch?v=w8d0w38n-eI [last accessed 15/1/2023]</ref> | |||
== Advantages == | == Advantages == | ||
| Line 49: | Line 32: | ||
== Evidence == | == Evidence == | ||
This tool has been a licenced product since November 2020 and has now been accredited by NHS England for use in personalised care service and has been developed into a digital tool. | |||
== Resources == | == Resources == | ||
* [https://www.meaningfulmeasures.co.uk/mymop Meaningful Measures website | * [https://www.meaningfulmeasures.co.uk/mymop MYMOP® Meaningful Measures website] | ||
== Related Articles == | == Related Articles == | ||
Latest revision as of 13:57, 11 March 2024
Original Editor - Abbey Wright
Top Contributors - Abbey Wright, Oyemi Sillo and Kim Jackson
Introduction[edit | edit source]
MYMOP® is a problem specific and individualised measure, which is brief and simple to use. was originally created in 1996.[1][2] MYMOP®' measures capture what patients consider are the two most important symptoms associated with a specific problem and an activity of daily living that is affected by these symptoms. MYMOP® also captures general wellbeing and is therefore applicable to all people who present with symptoms, whether physical, emotional or social. MYMOP® asks a person about medication use related to their problem and whether they want to cut this down.[3].
Description[edit | edit source]
The MYMOP tool is completed in the initial consultation. One or two symptoms are listed which are effected by the patient's condition such as "right leg weakness", this is then rated by the patient on a scale 0-6 taking into consideration their symptoms over the last week. This rating scale should be done by the patient and not influenced by the practitioner.[5]
- 0 being: "as good as it can be"
- 6 being: "as bad as it could be".
The patient would then choose an activity that has been effected by the symptom, and again rate the activity on a scale of 0-6 over the last week. The patient can also rate their well-being on the same scale however it is not essential for the data analysis.
A minimum clinically important change in score after intervention should be between 0.5-1.0: any change greater than 1.0 can be considered clinically significant.[2]
Advantages[edit | edit source]
- Patient centered[5]
- The MYMOP has been shown to be effective at measuring clinical effectiveness associated with acupuncture treatments which are typically difficult to prove clinical improvement. [7]
- Simple to administer[7]
- Sensitive to clinical change[7][8]
- Can be used in acute or persistent conditions[2]
- Improves patient-practitioner communication[8]
Disadvantages[edit | edit source]
The initial version was criticized due to it not including information regarding medication used for the condition, this has been added in the second version of the MYMOP2 (which is pictured above).[9] It does require some therapist involvement on the initial questionnaire so is not suitable for postal use.
It also requires patients to list the "most severe" problems so in patients with multiple issues it can be difficult for them to identify the most severe problem.
Evidence[edit | edit source]
This tool has been a licenced product since November 2020 and has now been accredited by NHS England for use in personalised care service and has been developed into a digital tool.
Resources[edit | edit source]
Related Articles[edit | edit source]
Further patient specific measures include:
- Patient Specific Functional Scale
- Quality of Life measures that have been used in multiple studies referenced on this page include:
- EQ-5D
- SF36 (Short Form 36)
References[edit | edit source]
- ↑ Mirza S, Salisbury C, Hopper C, Foster N, Montgomery A. Comparing sensitivity to change of two patient-reported outcome measures in a randomised trial of patients referred for physiotherapy services. Trials. 2013 Nov 1;14(S1):O50.
- ↑ 2.0 2.1 2.2 Polus BI, Kimpton AJ, Walsh MJ. Use of the measure your medical outcome profile (MYMOP2) and W-BQ12 (Well-Being) outcomes measures to evaluate chiropractic treatment: an observational study. Chiropractic & manual therapies. 2011 Dec;19(1):7.
- ↑ Paterson C, Langan CE, McKaig GA, Anderson PM, Maclaine GD, Rose LB, Walker SJ, Campbell MJ. Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D). Quality of Life Research. 2000 May 1;9(5):521-7.
- ↑ getwelluk. What is MYMOP? Available from: http://www.youtube.com/watch?v=IS4pblMO5RI [last accessed 15/1/2023]
- ↑ 5.0 5.1 Hermann K, Kraus K, Herrmann K, Joos S. A brief patient-reported outcome instrument for primary care: German translation and validation of the Measure Yourself Medical Outcome Profile (MYMOP). Health and quality of life outcomes. 2014 Dec;12(1):112.
- ↑ getwelluk. How Do I Use MYMOP? Available from: http://www.youtube.com/watch?v=w8d0w38n-eI [last accessed 15/1/2023]
- ↑ 7.0 7.1 7.2 Hull SK, Page CP, Skinner BD, Linville JC, Coeytaux RR. Exploring outcomes associated with acupuncture. Journal of Alternative & Complementary Medicine. 2006 Apr 1;12(3):247-54.
- ↑ 8.0 8.1 Paterson C. Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. Bmj. 1996 Apr 20;312(7037):1016-20.
- ↑ Paterson C, Britten N. In pursuit of patient-centred outcomes: a qualitative evaluation of the ‘Measure Yourself Medical Outcome Profile’. Journal of health services research & policy. 2000 Jan;5(1):27-36.
